ArticleAdvanced healthcare materials2026
A Biomimetic Buffering Hydrogel Scaffold for Long-Term Culture of Patient-Derived Tumor Organoids.
Article in Advanced healthcare materials, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Focused ultrasound for cellular mechanoactivation and nanomedicine delivery in cancer.Biomedical microdevices · 2026Review
- A Biomimetic Buffering Hydrogel Scaffold for Long-Term Culture of Patient-Derived Tumor Organoids.Advanced healthcare materials · 2026Article
- Advances in the Research and Development of Breast Cancer Organoids.Oncology research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Patient-derived cancer organoids have emerged as a promising in vitro model for fundamental cancer research and drug screening for therapeutic cancer treatment. Yet, while the inherent acidification of the tumor environment in vivo is controlled at a particular level, hydrogel scaffolds used for organoid culture lack this ability and their pH falls outside the physiologically relevant range. The excessive acidification can also lead to the degradation of pH-sensitive hydrogel scaffolds during long-term organoid culture, thus changing the mechanical properties of the organoid microenvironment. Here, we report a biomimetic fibrous hydrogel with built-in buffering capacity, which enables control of the local acidification of the organoid environment to maintain its mechanical and structural stability. The hydrogel is formed from aldehyde-functionalized cellulose nanocrystals carrying histidine buffering molecules, and gelatin. During long-term organoid culture, the hydrogel maintained the pH in the physiologically relevant range, while maintaining network integrity and mechanical properties. The organoids grown in this hydrogel exhibited enhanced proliferative activity of cancer cells, thus reflecting a more homeostatic tumor-like niche. This work shows that introducing a buffering functionality into the hydrogel scaffold enables significantly improved support for long-term culture of patient-derived breast cancer organoids under physiologically relevant conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.